Status:
TERMINATED
Blood Products Transfusion in Cardiac Surgery After the Implementation of a Coagulation Monitoring System at Patient Bedside: Thromboelastometry Versus Standard Transfusion Protocol
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
Hemostatic Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Main objective: Determine whether by introducing thromboelastograph, the investigators reduced the number of packed red cells received by each patient (median) compared to the usual protocol, in whic...
Eligibility Criteria
Inclusion
- Male and female patients
- over 18 years
- undergoing cardiac surgery
- with cardiopulmonary bypass
- bleed excessively
- As it is not possible to predict in advance who will bleed, informed consent will be required for all patients over 18 who are to undergo cardiac surgery with CPB.
- Will be randomized to either group
- Those patients with diffuse bleeding after protamine administration. and / or
- They bleed excessively after surgery. Are excessive bleeding criteria: the debit ≥ 300ml drains in the first hour; ≥ 250ml in the second hour or ≥ 150ml at any later time. Consider that the patient is bleeding excessively when the drains debit is \<150ml.
Exclusion
- Patients \<18 years
- Extracorporeal circulation surgery
- Surgery with Mini extracorporeal circulation (MECC)
- Refuse to participate in the study.
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT01919840
Start Date
February 1 2010
End Date
September 1 2011
Last Update
August 9 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.